548 filings
Page 5 of 28
SD
ie2j6z
21 May 20
Conflict minerals disclosure
4:45pm
8-K
bflkewxv6qt1xy8m mdn
12 May 20
Other Events
6:23am
8-K
f5m3w
30 Apr 20
Abiomed Announces Q4 Fy 2020 Revenue of $207 Million and 28.1% Operating Margin
7:38am
8-K
65b1c90
6 Feb 20
Abiomed Announces Q3 Fy 2020 Revenue of $222 Million and 31.7% Operating Margin
7:26am
8-K
8db6gmf5pr2968cabq
13 Jan 20
Abiomed Announces Preliminary Q3 Fy 2020 Revenue of $222 Million, Up 10% Over Prior Year
8:38am
8-K
vj9jg
31 Oct 19
Abiomed Announces Q2 Fy 2020 Revenue of $205 Million and 29.4% Operating Margin
7:14am
8-K
7v4 qoxnly6e53f
9 Aug 19
Submission of Matters to a Vote of Security Holders
4:37pm
8-K
vtyz5y qvq
5 Aug 19
Other Events
6:44am
8-K
ewa9c99b801 iuo63
1 Aug 19
Abiomed Announces Q1 Fy 2020 Revenue of $208 Million and 29.2% Operating Margin
7:18am
DEFA14A
csxg1k hk
25 Jun 19
Additional proxy soliciting materials
9:09am
8-K
ul7s hd3g
3 Jun 19
Departure of Directors or Certain Officers
4:10pm
SD
f9q2bbucsr p6ev9vu
23 May 19
Conflict minerals disclosure
4:15pm
8-K
1ajt wn8zbkxyci
2 May 19
Abiomed Announced Q4 Fy 2019 Revenue of $207 Million and 31.6% Operating Margin
7:14am